Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Manufacture of clinical grade human placenta-derived multipotent mesenchymal stromal cells.

Methods in molecular biology (Clifton, N.J.) - 1 Jan 2011

Ilic Nina, Brooke Gary, Murray Patricia, Barlow Sarah, Rossetti Tony, Pelekanos Rebecca, Hancock Sonia, Atkinson Kerry

Abstract excerpt

Clinical grade human mesenchymal stem cells (MSC) are manufactured and used in clinical trials for a range of regenerative and inflammatory diseases. Human MSC have now been derived from tissues other than bone marrow, such as placenta, as described in this laboratory protocol. It provides instructions for clinical grade MSC manufacturing according to the Code of Good Manufacturing Practice (cGMP) principles and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Culture Techniques
Share to Cell Nucleus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Separation

Share to Cryopreservation

Share to Flow Cytometry

Share to Mesenchymal Stem Cells

Share to Multipotent Stem Cells

Share to Placenta

Source

Identifiers

PMID: 21431513
DOI: 10.1007/978-1-60761-999-4_8

Genes

MSC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Manufacture of clinical grade human placenta-derived multipotent mesenchymal stromal cells.PMID 21431513Read ↗

Comparison of Human Placenta- and Bone Marrow–Derived Multipotent Mesenchymal Stem CellsSemantic proximity Read ↗

Mesenchymal Stem Cells for Therapeutic PurposesSemantic proximity Read ↗

Quality assessment of a serum and xenofree medium for the expansion of human GMP-grade mesenchymal stromal cells.Semantic proximity Read ↗

Harmonised culture procedures minimise but not eliminate mesenchymal stromal cell donor and tissue variability in a decentralized multicentre manufacturing approachSemantic proximity Read ↗

Distinct biological characteristics of mesenchymal stem cells separated from different components of human placentaSemantic proximity Read ↗

How far are we from the clinical use of placental-derived mesenchymal stem cells?Semantic proximity Read ↗

Novel isolation strategy to deliver pure fetal-origin and maternal-origin mesenchymal stem cell (MSC) populations from human term placentaSemantic proximity Read ↗

Multipotent mesenchymal stem cells from human placenta: critical parameters for isolation and maintenance of stemness after isolationSemantic proximity Read ↗

Isolation and characterisation of mesenchymal stem cells derived from human placenta tissueSemantic proximity Read ↗

Multicentre comparison of biological and functional properties of mesenchymal stromal cells from different sources cultivated using a harmonised manufacturing workflowSemantic proximity Read ↗

Isolation of Multipotent Cells from Human Term PlacentaSemantic proximity Read ↗

Establishment and characterization of fetal and maternal mesenchymal stem/stromal cell lines from the human term placentaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.